IMS Health Announces $250 Million Share Repurchase Authorization

Go back to IMS Health Announces $250 Million Share Repurchase Authorization

Barclays Downgrades IMS Health Holdings (IMS) to Equalweight

December 17, 2015 7:31 AM EST

Barclays downgraded IMS Health Holdings (NYSE: IMS) from Overweight to Equalweight with a price target of $28.00 (from $33.00).

For an analyst ratings summary and ratings history on IMS Health Holdings click here. For more ratings news on IMS Health Holdings click here.

Shares of IMS Health Holdings closed at $25.71 yesterday.

... More